Kalvista Pharmaceuticals Inc (KALV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 10-2020 | 07-2020 | 04-2020 | 01-2020 | 10-2019 | |
| Sales | 0 | 0 | 0 | 1,577 | 3,920 |
| Gross Profit | N/A | N/A | N/A | 1,577 | 3,920 |
| Operating Expenses | 12,781 | 14,443 | 0 | 14,301 | 13,209 |
| Operating Income | -12,781 | -14,443 | N/A | -12,724 | -9,289 |
| Other Income | 2,355 | 3,629 | 0 | 3,433 | 3,386 |
| Pre-tax Income | -10,426 | -10,814 | 0 | -9,291 | -5,903 |
| Net Income Continuous | -10,426 | -10,814 | N/A | -9,291 | -5,903 |
| Net Income | $-10,426 | $-10,814 | $N/A | $-9,291 | $-5,903 |
| EPS Basic Total Ops | -0.58 | -0.61 | N/A | -0.52 | -0.33 |
| EPS Basic Continuous Ops | -0.58 | -0.61 | N/A | -0.52 | -0.33 |
| EPS Diluted Total Ops | -0.58 | -0.61 | N/A | -0.52 | -0.33 |
| EPS Diluted Continuous Ops | -0.58 | -0.61 | N/A | -0.52 | -0.33 |
| EBITDA(a) | $-12,263 | $-14,443 | $N/A | $-12,206 | $-9,033 |